Stevanato Group (NYSE:STVN) Rating Increased to Strong-Buy at Stephens

Stevanato Group (NYSE:STVN - Get Free Report) was upgraded by analysts at Stephens to a "strong-buy" rating in a note issued to investors on Monday, April 21st,Zacks.com reports.

Other equities research analysts also recently issued research reports about the company. UBS Group dropped their target price on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating for the company in a research report on Friday, March 7th. William Blair reiterated an "outperform" rating on shares of Stevanato Group in a research report on Friday, March 7th. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Stevanato Group has a consensus rating of "Moderate Buy" and a consensus price target of €25.70 ($29.20).

Stevanato Group Price Performance

STVN traded up €0.14 ($0.16) during trading on Monday, hitting €21.73 ($24.69). The company's stock had a trading volume of 69,920 shares, compared to its average volume of 340,426. The firm's 50 day moving average price is €20.76 and its two-hundred day moving average price is €20.77. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The stock has a market capitalization of $6.58 billion, a price-to-earnings ratio of 46.23, a price-to-earnings-growth ratio of 7.18 and a beta of 0.52. Stevanato Group has a 12 month low of €16.56 ($18.82) and a 12 month high of €28.77 ($32.69).

Stevanato Group (NYSE:STVN - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.23) EPS for the quarter, hitting analysts' consensus estimates of €0.20 ($0.23). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The firm had revenue of €352.68 million for the quarter, compared to analyst estimates of €346.26 million. Sell-side analysts forecast that Stevanato Group will post 0.5 earnings per share for the current fiscal year.

Institutional Trading of Stevanato Group

Hedge funds have recently added to or reduced their stakes in the business. TimesSquare Capital Management LLC lifted its holdings in shares of Stevanato Group by 114.6% during the 4th quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company's stock valued at $71,657,000 after purchasing an additional 1,756,100 shares in the last quarter. Jennison Associates LLC acquired a new position in shares of Stevanato Group during the 4th quarter worth approximately $20,239,000. Frontier Capital Management Co. LLC lifted its stake in Stevanato Group by 1,012.0% in the fourth quarter. Frontier Capital Management Co. LLC now owns 1,003,235 shares of the company's stock valued at $21,860,000 after acquiring an additional 913,019 shares during the last quarter. Mutual of America Capital Management LLC acquired a new position in Stevanato Group during the fourth quarter worth approximately $13,848,000. Finally, Ranger Investment Management L.P. bought a new stake in Stevanato Group in the 4th quarter valued at $12,940,000.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.